Charles E. Vejnar
- Aging top 1%
- Cancer Research top 1%
- MicroRNA in disease regulation 9
- Molecular Biology top 2%
- RNA Research and Splicing 12
- RNA modifications and cancer 10
- RNA and protein synthesis mechanisms 8
- CRISPR and Genetic Engineering 7
- Advanced biosensing and bioanalysis techniques 6
- RNA Interference and Gene Delivery 4
- Endocrine and Autonomic Systems top 10%
-
- Reproductive Biology and Fertility 4
- Co-authors
- Antonio J. GiráldezEvgeny M. ZdobnovMiguel A. Moreno-MateosMustafa K. KhokhaJuan Pablo FernándezJean-Denis BeaudoinEmily K. MisAriel Bazzini
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Charles E. Vejnar
33 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Aging 162
- Cancer Research 1.1k
- Business and International Management 86
- Molecular Biology 3.0k
- Endocrine and Autonomic Systems 105
Countries citing papers authored by Charles E. Vejnar
This map shows the geographic impact of Charles E. Vejnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Vejnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Vejnar more than expected).
Fields of papers citing papers by Charles E. Vejnar
This network shows the impact of papers produced by Charles E. Vejnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Vejnar. The network helps show where Charles E. Vejnar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles E. Vejnar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 56 | |
| 5 | 2023 | 9 | |
| 6 | 2022 | 33 | |
| 7 | 2022 | 13 | |
| 8 | 2021 | 25 | |
| 9 | 2020 | 13 | |
| 10 | 2019 | 48 | |
| 11 | 2018 | 87 | |
| 12 | 2018 | 40 | |
| 13 | CRISPR-Cpf1 mediates efficient homology-directed repair and temperature-controlled genome editingbreakdown → | 2017 | 206 |
| 14 | 2016 | 29 | |
| 15 | CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivobreakdown → | 2015 | 880 |
| 16 | Transposable sequence evolution is driven by gene context | 2012 | 2 |
| 17 | 2010 | 52 | |
| 18 | 2010 | 90 | |
| 19 | 2009 | 315 | |
| 20 | 2008 | 155 |
About Charles E. Vejnar
Charles E. Vejnar is a scholar working on Aging, Cancer Research, Molecular Biology, Reproductive Medicine and Physiology, having authored 33 papers that have together received 3.6k indexed citations. Recurring topics across this work include RNA Research and Splicing (12 papers), RNA modifications and cancer (10 papers), MicroRNA in disease regulation (9 papers), RNA and protein synthesis mechanisms (8 papers), CRISPR and Genetic Engineering (7 papers), Advanced biosensing and bioanalysis techniques (6 papers), Reproductive Biology and Fertility (4 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Aging (162 citations), Cancer Research (1.1k citations), Business and International Management (86 citations), Molecular Biology (3.0k citations) and Endocrine and Autonomic Systems (105 citations). Charles E. Vejnar has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Antonio J. Giráldez, Evgeny M. Zdobnov, Miguel A. Moreno-Mateos, Mustafa K. Khokha, Juan Pablo Fernández, Jean-Denis Beaudoin, Emily K. Mis, Ariel Bazzini, Timothy G. Johnstone and Olivier Schaad. Their work appears in journals such as Nature Communications, Nucleic Acids Research, Nature Methods, Cell Reports and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.